Home / Companies / Wallac Oy, A Subsidiary of Perkinelmer

Wallac Oy, A Subsidiary of Perkinelmer

FDA Regulatory Profile

Wallac Oy, A Subsidiary of Perkinelmer appears in FDA public data with 0 recalls, 4 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent 510(k) clearance was granted on July 18, 2018.

Summary

Total Recalls
0
510(k) Clearances
4
Inspections
0
Compliance Actions
0

Recent 510(k) Clearances

K-NumberDeviceDate
K173829NeoLSD MSMS kitJuly 18, 2018
K133652GSP NEONATAL TOTAL GALACTOSE KITApril 28, 2014
K110274AUTODELFIA NEONATAL IRT KITJune 10, 2011
K103484GSP NEONATAL THYROXINE (T4)April 22, 2011

FDA data resources